# The Central Virginia Center on Drug Abuse Research

> **NIH NIH P30** · VIRGINIA COMMONWEALTH UNIVERSITY · 2020 · $1,352,218

## Abstract

Project Summary – Overall
One of the overall goals of this center is to provide an environment in which investigators can conduct new,
significant and innovative basic and clinical research utilizing bioanalytical technology, genetically altered mice,
neurobehavioral measures and gastrointestinal studies to advance our knowledge of the effects of abused drugs
on biological systems. Coordination through the Administrative Core will provide the necessary scientific,
financial, and administrative infrastructure to support such an environment. Further, this center will provide these
areas of expertise to enhance the research of the 21 projects in VCU's Department of Pharmacology and
Toxicology currently funded by NIDA and 13 funded through other NIH institutes (NIAAA: 2; NINDS: 2; NIGMS:
1; NCI: 1; NIDDKD: 4; NHLBI: 2) or other federal agencies (NSF: 1). These cores will provide current and
innovative expertise that is improved over the methodologies used in previously funded research. This will
enhance previously funded research and foster new collaborative research in ways that could not have been
contemplated just a few years ago. A Bioanalytical Core, Mutant Mouse/Viral Vector Core,
Neuropharmacology Core, and a Gastrointestinal Function Core will provide the opportunity for funded
researchers to broaden the scope of their work to transform knowledge in various creative ways. The ability to
continue to provide genetically altered mice with appropriate genotyping, etc., and expertise in viral vector
technology are major assets of this Center. Being able to have a collaborator elucidate receptor functional
changes as part of the neuropharmacology core, identify a substance found to alter behavior or craving in the
bioanalytical core, or identify deleterious effects in the gastrointestinal tract provides the atmosphere for new
and creative mechanistic research. This type of collaboration among scientists at different institutions is rare
and requires many months or perhaps years to establish, if at all. In this center this type of collaboration will be
the norm. We are committed to providing considerable institutional support, such as the use of a modern imaging
center and a forensic toxicology laboratory established by the university. We have commitments from the Dean
of the School of Medicine, the Dean of the School of Pharmacy, and the Vice President for Research and
Innovation to provide matching funds for our Pilot Projects program. The cores will also be available for
use by NIDA-funded investigators at the University of Virginia and Eastern Virginia Medical School. Scholars at
the relatively new Pharmacy School at Hampton University have begun collaborations with our researchers, as they
continue to develop and expand their research programs. We will also continue to share all aspects of this
center with scientists throughout the country. We have included numerous letters of support from collaborating
investigators at other institutions withi...

## Key facts

- **NIH application ID:** 9944472
- **Project number:** 5P30DA033934-07
- **Recipient organization:** VIRGINIA COMMONWEALTH UNIVERSITY
- **Principal Investigator:** William L. Dewey
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $1,352,218
- **Award type:** 5
- **Project period:** 2013-12-01 → 2024-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9944472

## Citation

> US National Institutes of Health, RePORTER application 9944472, The Central Virginia Center on Drug Abuse Research (5P30DA033934-07). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/9944472. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*